Skip to the page

Data / Form D filings / D2 Pharma Consulting LLC

D2 Pharma Consulting LLC: Form D filing

D2 Pharma Consulting LLC, a health care company in Chesterfield, MO, filed a Form D with the SEC in 2023. The latest, on January 10, 2023, reports $1.6 million sold of a $3 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
400 CHESTERFIELD CENTER, SUITE 400, Chesterfield, MO, 63017
Phone
(636) 537-7805
Industry
Other Health Care
Entity type
Limited Liability Company
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1961414

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 10, 2023New notice$3,000,000$1,600,000$1,400,0004Dec 28, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Dean P ErhardtExecutive Officer, Director
Steven P KirchofDirector
Richard P PropperDirector
John P WagnerDirector
David P SuchanekDirector

Other health care companies in Missouri that filed recently

Every Form D from the week of Jan 9, 2023 · All recent filings in Missouri · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what D2 Pharma Consulting LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.